ATE427320T1 - Behandlung von infektionen verursacht von mikroorganismen - Google Patents
Behandlung von infektionen verursacht von mikroorganismenInfo
- Publication number
- ATE427320T1 ATE427320T1 AT02777534T AT02777534T ATE427320T1 AT E427320 T1 ATE427320 T1 AT E427320T1 AT 02777534 T AT02777534 T AT 02777534T AT 02777534 T AT02777534 T AT 02777534T AT E427320 T1 ATE427320 T1 AT E427320T1
- Authority
- AT
- Austria
- Prior art keywords
- microorganisms
- treatment
- infections caused
- antibody
- daptomycin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
- C07K16/1271—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Micrococcaceae (F), e.g. Staphylococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/40—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum bacterial
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Mycology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0127983.5A GB0127983D0 (en) | 2001-11-22 | 2001-11-22 | Treatment of micro-organism infection |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE427320T1 true ATE427320T1 (de) | 2009-04-15 |
Family
ID=9926237
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT02777534T ATE427320T1 (de) | 2001-11-22 | 2002-11-13 | Behandlung von infektionen verursacht von mikroorganismen |
Country Status (18)
Country | Link |
---|---|
US (3) | US20050118162A1 (de) |
EP (2) | EP1964851A1 (de) |
JP (1) | JP2005511645A (de) |
CN (2) | CN101254304A (de) |
AT (1) | ATE427320T1 (de) |
AU (2) | AU2002339159B2 (de) |
BR (1) | BR0214363A (de) |
CA (1) | CA2465072A1 (de) |
DE (1) | DE60231825D1 (de) |
DK (1) | DK1446425T3 (de) |
ES (1) | ES2322756T3 (de) |
GB (1) | GB0127983D0 (de) |
NO (2) | NO20042604L (de) |
NZ (1) | NZ533623A (de) |
PL (1) | PL369536A1 (de) |
PT (1) | PT1446425E (de) |
RU (1) | RU2303460C2 (de) |
WO (1) | WO2003046007A2 (de) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0127983D0 (en) * | 2001-11-22 | 2002-01-16 | Neutec Pharma Plc | Treatment of micro-organism infection |
US20070202186A1 (en) | 2006-02-22 | 2007-08-30 | Iscience Interventional Corporation | Apparatus and formulations for suprachoroidal drug delivery |
JP5248032B2 (ja) * | 2007-04-23 | 2013-07-31 | 株式会社Adeka | ケイ素含有化合物、硬化性組成物及び硬化物 |
JP5248033B2 (ja) * | 2007-04-23 | 2013-07-31 | 株式会社Adeka | ケイ素含有化合物、硬化性組成物及び硬化物 |
US20100113355A1 (en) | 2007-04-27 | 2010-05-06 | Naresh Chennamsetty | Novel antibody molecules and nucleic acids binding to fungal stress protein hsp90 |
WO2008132174A1 (en) * | 2007-04-27 | 2008-11-06 | Novartis Ag | An immunoglobulin composition |
ES2537437T3 (es) * | 2009-05-18 | 2015-06-08 | Julius-Maximilians-Universität Würzburg | Anticuerpos o fragmentos de éstos dirigidos contra un epítopo del Staphylococcus aureus de IsaA o IsaB |
SG177653A1 (en) * | 2009-07-15 | 2012-02-28 | Aimm Therapeutics Bv | Gram-positive bacteria specific binding compounds |
US9005579B2 (en) | 2010-01-05 | 2015-04-14 | Contrafect Corporation | Methods and compositions for enhanced immunological therapy and targeting of gram-positive bacteria |
JP5996544B2 (ja) | 2010-10-15 | 2016-09-21 | クリアサイド・バイオメディカル・インコーポレーテッドClearside Biomedical Incorporated | 眼球アクセス用装置 |
AU2011317021B2 (en) * | 2010-10-20 | 2015-07-09 | Medimmune, Llc | Methods for processing inclusion bodies |
CN110302004B (zh) | 2013-05-03 | 2023-04-28 | 科尼尔赛德生物医学公司 | 用于眼部注射的设备和方法 |
RU2572341C2 (ru) * | 2013-09-20 | 2016-01-10 | Федеральное государственное бюджетное учреждение Научно-исследовательский институт по изысканию новых антибиотиков имени Г.Ф. Гаузе Российской академии медицинских наук (ФГБУ "НИИНА" РАМН) | АНТИБИОТИК ИНА 5812, ШТАММ-ПРОДУЦЕНТ Streptomyces roseoflavus ИНА-Ас-5812 И СПОСОБ ПОЛУЧЕНИЯ АНТИБИОТИКА |
CA3062845A1 (en) | 2016-05-02 | 2017-11-09 | Clearside Biomedical, Inc. | Systems and methods for ocular drug delivery |
US10973681B2 (en) | 2016-08-12 | 2021-04-13 | Clearside Biomedical, Inc. | Devices and methods for adjusting the insertion depth of a needle for medicament delivery |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8607679D0 (en) | 1986-03-27 | 1986-04-30 | Winter G P | Recombinant dna product |
NZ291659A (en) * | 1994-09-06 | 2001-04-27 | Galagen Inc | Use in the manufacture of a medicament of an antibody having specific activity against Clostridium difficile, and pharmaceutical compositions comprising Anti-Clostridium difficile bovine immunoglobulin concentrate; for treating diseases associated with Clostridium difficile |
GB9614274D0 (en) * | 1996-07-06 | 1996-09-04 | Univ Manchester | Treatment and diagnosis of infections of gram positive cocci |
GB9806762D0 (en) * | 1998-03-31 | 1998-05-27 | Neutec Pharma Plc | Treatment and diagnosis of staphylococcal infections |
GB0127983D0 (en) * | 2001-11-22 | 2002-01-16 | Neutec Pharma Plc | Treatment of micro-organism infection |
-
2001
- 2001-11-22 GB GBGB0127983.5A patent/GB0127983D0/en not_active Ceased
-
2002
- 2002-11-13 EP EP08005286A patent/EP1964851A1/de not_active Withdrawn
- 2002-11-13 WO PCT/GB2002/005135 patent/WO2003046007A2/en active IP Right Grant
- 2002-11-13 DE DE60231825T patent/DE60231825D1/de not_active Expired - Lifetime
- 2002-11-13 CN CNA2008100036489A patent/CN101254304A/zh active Pending
- 2002-11-13 AT AT02777534T patent/ATE427320T1/de not_active IP Right Cessation
- 2002-11-13 PT PT02777534T patent/PT1446425E/pt unknown
- 2002-11-13 RU RU2004118716/13A patent/RU2303460C2/ru not_active IP Right Cessation
- 2002-11-13 JP JP2003547456A patent/JP2005511645A/ja active Pending
- 2002-11-13 BR BR0214363-1A patent/BR0214363A/pt not_active IP Right Cessation
- 2002-11-13 NZ NZ533623A patent/NZ533623A/en not_active IP Right Cessation
- 2002-11-13 CN CNB028231783A patent/CN100371348C/zh not_active Expired - Fee Related
- 2002-11-13 CA CA002465072A patent/CA2465072A1/en not_active Abandoned
- 2002-11-13 DK DK02777534T patent/DK1446425T3/da active
- 2002-11-13 PL PL02369536A patent/PL369536A1/xx not_active IP Right Cessation
- 2002-11-13 ES ES02777534T patent/ES2322756T3/es not_active Expired - Lifetime
- 2002-11-13 AU AU2002339159A patent/AU2002339159B2/en not_active Ceased
- 2002-11-13 US US10/496,507 patent/US20050118162A1/en not_active Abandoned
- 2002-11-13 EP EP02777534A patent/EP1446425B1/de not_active Expired - Lifetime
-
2004
- 2004-06-21 NO NO20042604A patent/NO20042604L/no not_active Application Discontinuation
-
2007
- 2007-02-23 US US11/709,952 patent/US20070202116A1/en not_active Abandoned
- 2007-10-31 US US11/931,099 patent/US20080171054A1/en not_active Abandoned
-
2008
- 2008-03-31 NO NO20081575A patent/NO20081575L/no not_active Application Discontinuation
- 2008-09-04 AU AU2008212001A patent/AU2008212001A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
ES2322756T3 (es) | 2009-06-26 |
JP2005511645A (ja) | 2005-04-28 |
US20080171054A1 (en) | 2008-07-17 |
RU2004118716A (ru) | 2005-03-27 |
CA2465072A1 (en) | 2003-06-05 |
EP1446425B1 (de) | 2009-04-01 |
EP1446425A2 (de) | 2004-08-18 |
PL369536A1 (en) | 2005-05-02 |
DE60231825D1 (de) | 2009-05-14 |
NZ533623A (en) | 2005-12-23 |
CN100371348C (zh) | 2008-02-27 |
GB0127983D0 (en) | 2002-01-16 |
EP1964851A1 (de) | 2008-09-03 |
US20050118162A1 (en) | 2005-06-02 |
WO2003046007A3 (en) | 2004-03-11 |
NO20042604L (no) | 2004-06-21 |
AU2002339159B2 (en) | 2008-06-05 |
NO20081575L (no) | 2004-06-21 |
US20070202116A1 (en) | 2007-08-30 |
AU2008212001A1 (en) | 2008-09-25 |
CN101254304A (zh) | 2008-09-03 |
RU2303460C2 (ru) | 2007-07-27 |
CN1589280A (zh) | 2005-03-02 |
WO2003046007A2 (en) | 2003-06-05 |
AU2002339159A1 (en) | 2003-06-10 |
BR0214363A (pt) | 2004-10-26 |
PT1446425E (pt) | 2009-07-01 |
DK1446425T3 (da) | 2009-07-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20081575L (no) | Behandling av mikroorganismeinfeksjoner | |
FR12C0004I2 (fr) | Anticorps contre l'antigene ctla-4 humain et utilisation | |
HK1069316A1 (en) | Hmgb1 protein inhibitors and/or antagonists for the treatment of vascular diseases | |
HUP0301003A2 (hu) | Kazeinből származó peptidek és terápiás alkalmazásuk | |
DE602004025576D1 (de) | Varianten der faktor-vii- oder -viia-gla-domäne | |
IL132933A0 (en) | Composition for the treatment of diarrheal disease | |
DE69914911D1 (de) | Pharmazeutische präparate zur bekämpfung oder prophylaxe von mikroorganismen infizierten oberflächen | |
ATE258057T1 (de) | Therapeutische und diagnostische agenzien zur behandlung mikrobieller infektionen | |
ATE403726T1 (de) | Cytokin-proteinfamilie | |
DE60332425D1 (de) | 5t4-antigen-peptidepitope der mhc klasse ii | |
DE69330268D1 (de) | Hämoregulierende peptide | |
GB0203419D0 (en) | Peptide | |
RS49520B (sr) | Antimikrobno aktivne smeše | |
EP1557466A4 (de) | Tumorantigenprotein und dessen verwendung | |
NZ508812A (en) | Peptides for the prevention or treatment of HIV | |
WO2004042043A3 (en) | Crystal structures of bacterial ribulose-phosphate 3-epimerases | |
ATE212839T1 (de) | Hämoregulatorische verbindungen | |
WO2004041856A3 (en) | Crystal structures of bacterial inorganic pyrophosphatases | |
WO2003027274A3 (en) | Purified polypeptides from pseudomonas aeruginosa | |
WO2003048187A3 (en) | Peptides and use thereof in therapeutic agents against hiv infection | |
WO2004058811A3 (en) | Crystal structures of yhhf polypeptides | |
DE602004003508D1 (de) | Aus pflanzen gewonnene peptide mit wasserreinigender und antimikrobieller wirkung | |
CO4820441A1 (es) | Antigeno bm 95 de la garrapata boophilus microplus, aislamiento, secuencia, adn recombinantes, microorganismos transformados y preparacion vacunal | |
MX9800686A (es) | Nueva proteina hmw humana mp52s. | |
WO2003055904A3 (en) | Peptidyl-trna hydrolase from pseudomonas aeruginosa |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1446425 Country of ref document: EP |
|
REN | Ceased due to non-payment of the annual fee |